Viewing StudyNCT00142571



Ignite Creation Date: 2024-05-05 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00142571
Status: COMPLETED
Last Update Posted: 2007-10-02
First Post: 2005-08-31

Brief Title: Comparison of Gemcitabine v Gemcitabine Plus Docetaxel in Unresectable Soft Tissue Sarcoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization: Memorial Sloan Kettering Cancer Center

Conditions & Keywords Data

Conditions:
Name
Sarcoma Soft Tissue
Keywords:
Name View
Docetaxel View
Sarcoma Soft Tissue View
Gemcitabine View